ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      59,987.15
      1.27%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Amylin Pharmaceuticals, Inc. (MM) (AMLN)

      7. Amylin Pharmaceuticals, Inc. (MM) (AMLN) News

      AMLN

      Amylin Pharmaceuticals, Inc. (MM) (AMLN)

      Amylin Pharmaceuticals, Inc. (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AMLN
      DateTimeSourceHeadlineSymbolCompany
      12/18/20037:30AMPR Newswire (US)Amylin Pharmaceuticals to Webcast Corporate Update Conference CallNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      12/17/20036:44PMPR Newswire (US)Amylin Pharmaceuticals Receives Second Approvable Letter for SYMLIN(R)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      12/11/20034:30PMPR Newswire (US)Amylin Pharmaceuticals Files Shelf Registration StatementNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      11/24/20034:30PMPR Newswire (US)Amylin Pharmaceuticals to Webcast Corporate Update Conference CallNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      11/24/20034:15PMPR Newswire (US)Positive Results from Final Exenatide Pivotal Study Mark Successful Completion of Phase 3NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      11/10/20034:15PMPR Newswire (US)Exenatide Continues to Generate Positive Results in Second of Three Phase 3 StudiesNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      11/04/20037:30AMPR Newswire (US)Amylin Pharmaceuticals Reports Third Quarter Financial ResultsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/31/20037:30AMPR Newswire (US)Amylin Pharmaceuticals Names Michael Hanley As Vice President of Discovery ResearchNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/30/20037:30AMPR Newswire (US)Amylin Pharmaceuticals to Webcast Third Quarter Company Update Conference CallNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
       Showing the most relevant articles for your search:NASDAQ:AMLN